MUC1 and familial pancreatic carcinoma: When adoptively transferred, MUC-1 specific T cells showed strong tumour cytotoxicity, providing a rationale for the use of adjuvant immunotherapy via adoptive cell transfer in the treatment of pancreatic cancer [142,143].